Effects of avastin on expression of AQP4 in Müller cells under hypoxia

Abstract

The aim of this study was to investigate the effects of Avastin on aquaporin4 (AQP4) expression in human retinal Müller cells in vitro under hypoxia, so as to explore the mechanism of Avastin treating retinal edema. The human Müller cells were cultured using the enzymatic digestion method. Müller cells were identified under the transmission electron microscopy and by using immunofluorescence staining. By using semi-quantitative reverse transcription polymerase chain reaction (RT-PCR), the expression of AQP4 mRNA and VEGF mRNA in Müller cells cultured with 500 μmol/L CoCl₂ for 0, 3, 6, 12 and 24 h, and with 0, 100, 300, 500 and 700 μmol/L CoCl₂ for 24 h was detected. The expression of AQP4 mRNA in Müller cells cultured with 50 ng/mL exogenous vascular endothelial growth factor (VEGF) for 0, 0.5, 1, 2 and 4 h, and with 0, 25, 50 and 75 ng/mL VEGF for 24 h was detected. Amplified cDNA products of AQP4 mRNA in Müller cells cultured with 500 μmol/L CoCl₂ and 200 μg/mL Avastin for 24 h were detected. The results showed that more than 95% cells displayed positive immunofluorescence reaction. Characteristic 8–10 nm intracellular filaments could be seen in the cytoplasm under the transmission electron microscopy. In the CoCl₂ experimental groups, the expression of AQP4 mRNA and VEGF mRNA in Müller cells was increased as compared with the control group. Alteration of AQP4 mRNA and VEGF mRNA levels showed a significantly positive correlation (r²=0.822, P<0.05). The expression of AQP4 mRNA in Müller cells was increased by VEGF. The expression of AQP4 mRNA was significantly decreased by Avastin as compared with the control group. It is suggested that Avastin can decrease the expression of AQP4 mRNA in human Müller cells under chemical hypoxic conditions partially via VEGF path, which may be one of the mechanisms of Avastin treating retinal edema.

Keywords

Avastin / aquaporin4 / Müller cells / retinal edema / hypoxia

References

[1] ReichenbachA., WurmA., PannickeA.. Müller cells as players in retinal degeneration and edema. Graefes Arch Clin Exp Ophthalmol, 2007, 245(5): 627-636

[2] WangP., NiR.Y., ChenM.N., et al.. Expression of aquaporin-4 in human supratentorial meningiomas with peritumoral brain edema and correlation of VEGF with edema formation. Genet Mol Res, 2011, 10(3): 2165-2171

[3] MouK., ChenM., MaoQ., et al.. AQP-4 in peritumoral edematous tissue is correlated with the degree of glioma and with expression of VEGF and HIF-alpha. J Neurooncol, 2010, 100(3): 375-383

[4] GoodyearM.J., CrewtherS.G., JunghansB.M.. A role for aquaporin-4 in fluid regulation in the inner retina. Vis Neurosci, 2009, 26(2): 159-165

[5] PannickeT., IandievI., UckennasmO.. A potassium channel-linked mechanism of Müller cell swelling in the postischemie retina. Mol Cell Neurosci, 2004, 26(4): 493-502

[6] YafaiY., IandievI., WiedemannP., et al.. Retinal endothelial amgiogenic activity: effects of hypoxia and glial (Müller) cells. Microcirculation, 2004, 11(7): 577-586

[7] FunatsuH., YamashitaH., SakataK., et al.. Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema. Ophthalmology, 2005, 112(5): 806-816

[8] NomaH., FunatsuH., MimuraT., et al.. Visual prognosis and vitreous molecules after vitrectomy for macular edema with branch retinal vein occlusion. Clin Ophthalmol, 2011, 5: 223-229

[9] BaiY., MaJ.X., GuoJ., et al.. Müller cell-derived VEGF is a significant contributor to retinal neovascularization. J Pathol, 2009, 219(4): 446-454

[10] RiteI., MachadoA., CanoJ., et al.. Intracerebral VEGF injection highly upregulates AQP4 mRNA and protein in the perivascular space and glia limitans externa. Neurochem Int, 2008, 52(4–5): 897-903

[11] WangY.F., FanZ.K., CaoY., et al.. 2-Methoxyestradiol inhibits the up-regulation of AQP4 and AQP1 expression after spinal cord injury. Brain Res, 2011, 1370: 220-226

[12] HafitoglouC., KookD., NeubauerA., et al.. Intravitreal bevacizumab (Avastin) therapy for pemistent diffuse diabetic macular edema. Retina, 2006, 26(9): 999-1005

[13] JaisleG.B., ZiemssenF., PetermeierK., et al.. Bevaeizumab for treatment of macular edema secondary to retinal vein occlusion. Ophtludmologe, 2006, 103(6): 471-475

[14] SpaideR.F., FisherY.L.. Intravitreal bevacizumab (avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina, 2006, 26(3): 275-278

[15] Saint-GeniezM., MaharajA.S., WalsheT.E., et al.. Endogenous VEGF is required for visual function: evidence for a survival role on Müller cells and photoreceptors. D’Amore PA PLoS One, 2008, 3(11): e3554